Haisco Pharmaceutical Group

Profilo dell'azienda

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research collaboration with Eli Lilly and Company to develop medicines across multiple therapeutic areas. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.

Descrizione disponibile in inglese.

Dati societari

Settore

Salute

Industria

Biotechnology

Paese

Cina

Sede

No. 17 Sanxiang Avenue, 856000, Shannan

Dipendenti

5.597

Quotazione

002653 · SZSE

Valuta

CNY

Sito web

haisco.com